Why the study?
The study was designed to investigate the effects of heparin on in vitro stimulated platelet aggregation during elective percutaneous coronary intervention.
Does a heparin bolus affect in vitro stimulated platelet aggregation in patients undergoing elective percutaneous coronary intervention?
Does a heparin bolus affect in vitro stimulated platelet aggregation in patients undergoing elective percutaneous coronary intervention?
No results reported; leaves open heparin's effect on platelet aggregation during elective PCI.
The aim of the present study was to investigate the effects of heparin on in vitro stimulated platelet aggregation by elective percutaneous coronary intervention Methods: Thirty elective percutaneous coronary angioplasty (PTCA) patients were included in the present study. The patients were administered heparin as anticoagulant agent during PTCA. Two blood samples were obtained during the intervention before and 10 minutes after heparin bolus and stimulated platelet aggregation responses were investigated.
No takes yet. Share an insight, caveat, or question.
Türkoğlu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: